Text Message Treatment for Social Anxiety
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03562650 |
|
Recruitment Status :
Completed
First Posted : June 19, 2018
Last Update Posted : January 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Social Anxiety | Behavioral: Safety Behavior Fading Behavioral: Present Centered | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 97 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Active treatment and active treatment control conditions. |
| Masking: | Single (Participant) |
| Masking Description: | All participants are assigned to a condition and given a treatment justification, but are not told whether they are in the treatment or control condition. |
| Primary Purpose: | Treatment |
| Official Title: | Computerized Treatment for Social Anxiety |
| Actual Study Start Date : | January 27, 2018 |
| Actual Primary Completion Date : | March 27, 2019 |
| Actual Study Completion Date : | March 27, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Safety Behavior Fading
Participants are asked to pick their three most common safety behaviors from a list and then receive texts every other day for a month reminding them to fade those behaviors.
|
Behavioral: Safety Behavior Fading
Participants are asked to fade their three most common safety behaviors associated with their social anxiety |
|
Active Comparator: Present Centered
Participants receive texts every other day for a month asking them to try to focus on the present that day.
|
Behavioral: Present Centered
Participants are asked to try to increase their focus on the present. |
- Social Phobia Inventory (SPIN) [ Time Frame: Change in social anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks) ]Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.
- Subtle Avoidance Frequency Examination(SAFE) [ Time Frame: Change in safety behavior use from baseline to post treatment (4 weeks) and one month follow up (8 weeks) ]Self report scale used to assess how often people use safety behaviors to cope with their anxiety. Scores range from 33 to 165. Higher total scores are associated with more frequent safety behavior use.
- Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) [ Time Frame: Change in mindfulness from baseline to post treatment (4 weeks) and one month follow up (8 weeks) ]Self-report used to measure mindfulness, including awareness of thoughts and feelings. Total scores range from 12 to 48 with higher scores indicating a greater ability to be mindful, present in the moment, and aware of thoughts and feelings.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Social Phobia Inventory score > 29
Exclusion Criteria:
- receiving therapy
- changes in the past 4 weeks with medication for emotional difficulties
- psychotic symptoms
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03562650
| United States, Florida | |
| Florida State University, Department of Psychology | |
| Tallahassee, Florida, United States, 32306 | |
| Responsible Party: | Jesse Cougle, Associate Professor, Florida State University |
| ClinicalTrials.gov Identifier: | NCT03562650 |
| Other Study ID Numbers: |
2017.22461 |
| First Posted: | June 19, 2018 Key Record Dates |
| Last Update Posted: | January 29, 2021 |
| Last Verified: | January 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Anxiety Disorders Mental Disorders |

